The Journal of
Clinical Psychiatry

Empowering mental health professionals with peer-reviewed psychiatric research and insights

Back to top Open menu arrow
Current Issue Archives Authors Reviewers

Page 45

More JCP Articles

JCP
Add-on Pramipexole for Schizophrenia
Original Research

August 1, 2022

Several small clinical trials have reported that the dopamine agonist pramipexole was beneficial in treating patients with schizophrenia. This 16-week, multicenter, double-blind, randomized, placebo-controlled study was conducted to test…
, , , et al
JCP
Treatment of Early-Stage Alzheimer Disease
Educational Activity

August 1, 2022

Many new therapies for early-stage AD have made their way onto the scene that can delay onset of the disease and/or slow down progression. Find out the how, what,…
,
JCP
Depression Severity, Psychotic Depression, and Suicide Risk
Original Research

July 27, 2022

Depression is the strongest diagnostic predictor of suicide. This study investigated the role of depression severity in suicide risk by studying the predictive value of psychotic symptoms and depression…
, , , et al
JCP
The Practical Importance of Half-Life in Psychopharmacology
Clinical and Practical Psychopharmacology

July 25, 2022

Essential information on why it’s important to know the half-lives of drugs, how half-life may differ with individual patient characteristics, and how to use this knowledge to best advantage…
JCP
Predictors of Recurrence or Persistence in Panic Disorder
Original Research

July 25, 2022

The heterogeneous course of panic disorder necessitates the development of a comprehensive predictive model of recurrence or persistence for these patients. This study sought to build such a model…
, , , et al
JCP
Amphetamine Extended-Release Tablets for Adult ADHD
Original Research

July 20, 2022

Treating attention-deficit/hyperactivity disorder (ADHD) in adults can improve long-term outcomes, such as reducing suicidal behavior and mortality. This study evaluated the efficacy and safety of amphetamine extended-release tablets in…
, , , et al
JCP
Treatment-Resistant Mood Disorders in LGBTQ People
Original Research

July 18, 2022

In this chart review, LGBTQ people with treatment-resistant mood disorders had clinical features linked to worse outcomes, but their improvement with ECT was similar to that seen in non-LGBTQ…
, , , et al
JCP
Psychiatric Care Considerations for Sexually and Gender Diverse Populations
Commentary

July 18, 2022

Dr Keuroghlian discusses recent research by Oka et al on LGBTQ patients’ clinical characteristics and response to ECT.
JCP
Prevalence of Bipolar Disorder in Perinatal Women
Meta-Analysis

July 13, 2022

Perinatal women may be at increased risk for bipolar-spectrum mood episodes. This review and meta-analysis aimed to estimate overall prevalence of bipolar disorder and the prevalence and timing of…
, , , et al
JCP
Recognizing Bipolar Disorder in Pregnant and Postpartum Women
Editorial

July 13, 2022

In this editorial, Drs Freeman and Goldberg comment on a meta-analysis by Masters and colleagues on the prevalence of bipolar disorder in perinatal women.
,
JCP
In Memoriam: Jan Fawcett, MD
In Memoriam

July 11, 2022

A. John Rush and Steven D. Hollon reflect on Fawcett’s life and his contributions to the field, especially in the areas of treatment-resistant depression and suicide.
,
JCP
Elevated CCK With ARFID
Original Research

July 11, 2022

Avoidant/restrictive food intake disorder (ARFID) is characterized by food avoidance unmotivated by body weight/shape concerns. This study explored if levels of the satiety hormone cholecystokinin are higher in individuals…
, , , et al

Expert Consensus on Aripiprazole LAIs in Clinical Practice

Read the full report
Figure shows a syringe and vials with title on aripiprazole monohydrate LAI use in schizophrenia and a red READ NOW button.

Subscribe to read
more articles

Subscribe